year to be in parallel with the plunge in sales revenue. Nevertheless, some of the sales expenses did not adjust promptly and did not fully mirror the slowdown in revenue as there is a lead time for

reducing production cost and also negotiating with customers to review and adjust selling price every quarter. 2.2. Distribution costs for 2018 was in the amount of 4.95 million baht, increased by 1.16

with the plunge in sales revenue. Nevertheless, some of the sales expenses did not adjust promptly and did not fully mirror the slowdown in revenue as there is a lead time for certain expenses that the

granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change

issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures

that the Company managed to properly slash sales expenses from the previous year to be in parallel with the plunge in sales revenue. Nevertheless, some of the sales expenses did not adjust promptly and

a Private Visit to facilitate those who need to visit the project. In this regard, the Company will closely monitor the situation of COVID-19 and continuously adjust the operation pattern to keep up

benefit expenses For Quarter 2 of the year 2020, the management benefit was 3.24 million baht compare to 3.77 million baht, decrease by 0.53 million or 14.06% decreased because the company had adjust the

the sale volume decreased from the government’s policy to adjust the biodiesel mandatory. However, the average selling price of Glycerine was increased, resulting the increased in the performance from

informed accordingly Yours sincerely, (Associate Prof. Dr. Chiraphol Chiyachantana) Authorized person for disclosure of information Disposition of Assets and Related Transaction The Board of Directors of